These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 32806260)

  • 21. In vivo targeting of metastatic breast cancer via tumor vasculature-specific nano-graphene oxide.
    Yang D; Feng L; Dougherty CA; Luker KE; Chen D; Cauble MA; Banaszak Holl MM; Luker GD; Ross BD; Liu Z; Hong H
    Biomaterials; 2016 Oct; 104():361-71. PubMed ID: 27490486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Multi-Functional Tumor Theranostic Nanoplatform for MRI Guided Photothermal-Chemotherapy.
    Shi J; Wang B; Chen Z; Liu W; Pan J; Hou L; Zhang Z
    Pharm Res; 2016 Jun; 33(6):1472-85. PubMed ID: 26984128
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PEGylated doxorubicin cloaked nano-graphene oxide for dual-responsive photochemical therapy.
    Wang L; Yu D; Dai R; Fu D; Li W; Guo Z; Cui C; Xu J; Shen S; Ma K
    Int J Pharm; 2019 Feb; 557():66-73. PubMed ID: 30580088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amphiphilic prodrug-decorated graphene oxide as a multi-functional drug delivery system for efficient cancer therapy.
    Huang C; Wu J; Jiang W; Liu R; Li Z; Luan Y
    Mater Sci Eng C Mater Biol Appl; 2018 Aug; 89():15-24. PubMed ID: 29752084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design and evaluation of galactosylated chitosan/graphene oxide nanoparticles as a drug delivery system.
    Wang C; Zhang Z; Chen B; Gu L; Li Y; Yu S
    J Colloid Interface Sci; 2018 Apr; 516():332-341. PubMed ID: 29408121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Controlled release of doxorubicin from electrospun PEO/chitosan/graphene oxide nanocomposite nanofibrous scaffolds.
    Ardeshirzadeh B; Anaraki NA; Irani M; Rad LR; Shamshiri S
    Mater Sci Eng C Mater Biol Appl; 2015 Mar; 48():384-90. PubMed ID: 25579938
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Characters of Graphene Oxide Nanoparticles and Doxorubicin Against HCT-116 Colorectal Cancer Cells In Vitro.
    Banoon SR; Ghasemian A
    J Gastrointest Cancer; 2022 Jun; 53(2):410-414. PubMed ID: 33742370
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tracking the intracellular drug release from graphene oxide using surface-enhanced Raman spectroscopy.
    Huang J; Zong C; Shen H; Cao Y; Ren B; Zhang Z
    Nanoscale; 2013 Nov; 5(21):10591-8. PubMed ID: 24057012
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of a graphene oxide-poly lactide nanocomposite as a Smart Drug Delivery System.
    Ghamkhari A; Abbaspour-Ravasjani S; Talebi M; Hamishehkar H; Hamblin MR
    Int J Biol Macromol; 2021 Feb; 169():521-531. PubMed ID: 33340628
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functionalized graphene oxides for drug loading, release and delivery of poorly water soluble anticancer drug: A comparative study.
    Karki N; Tiwari H; Pal M; Chaurasia A; Bal R; Joshi P; Sahoo NG
    Colloids Surf B Biointerfaces; 2018 Sep; 169():265-272. PubMed ID: 29783152
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Green fabricated reduced graphene oxide: evaluation of its application as nano-carrier for pH-sensitive drug delivery.
    Ma N; Zhang B; Liu J; Zhang P; Li Z; Luan Y
    Int J Pharm; 2015 Dec; 496(2):984-92. PubMed ID: 26541300
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biocompatible graphene oxide nanoparticle-based drug delivery platform for tumor microenvironment-responsive triggered release of doxorubicin.
    Zhao X; Liu L; Li X; Zeng J; Jia X; Liu P
    Langmuir; 2014 Sep; 30(34):10419-29. PubMed ID: 25109617
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential pro-apoptotic effects of synthetic 4-thiazolidinone derivative Les-3288, doxorubicin and temozolomide in human glioma U251 cells.
    Коbylinska LI; Klyuchivska OY; Grytsyna II; Finiuk N; Panchuk RR; Starykovych MO; Lehka L; Lesyk RB; Zіmenkovsky BS; Stoika RS
    Croat Med J; 2017 Apr; 58(2):150-159. PubMed ID: 28409498
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Highly efficient nuclear delivery of anti-cancer drugs using a bio-functionalized reduced graphene oxide.
    Zheng XT; Ma XQ; Li CM
    J Colloid Interface Sci; 2016 Apr; 467():35-42. PubMed ID: 26773607
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Covalent modification of reduced graphene oxide by means of diazonium chemistry and use as a drug-delivery system.
    Wei G; Yan M; Dong R; Wang D; Zhou X; Chen J; Hao J
    Chemistry; 2012 Nov; 18(46):14708-16. PubMed ID: 23018420
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functionalized graphene oxide-based thermosensitive hydrogel for magnetic hyperthermia therapy on tumors.
    Zhu X; Zhang H; Huang H; Zhang Y; Hou L; Zhang Z
    Nanotechnology; 2015 Sep; 26(36):365103. PubMed ID: 26291977
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tailored graphene oxide-doxorubicin nanovehicles via near-infrared dye-lactobionic acid conjugates for chemo-photothermal therapy.
    Huang C; Hu X; Hou Z; Ji J; Li Z; Luan Y
    J Colloid Interface Sci; 2019 Jun; 545():172-183. PubMed ID: 30878783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mesoporous Silica Coated Polydopamine Functionalized Reduced Graphene Oxide for Synergistic Targeted Chemo-Photothermal Therapy.
    Shao L; Zhang R; Lu J; Zhao C; Deng X; Wu Y
    ACS Appl Mater Interfaces; 2017 Jan; 9(2):1226-1236. PubMed ID: 28004583
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular simulation of pH-dependent diffusion, loading, and release of doxorubicin in graphene and graphene oxide drug delivery systems.
    Mahdavi M; Rahmani F; Nouranian S
    J Mater Chem B; 2016 Dec; 4(46):7441-7451. PubMed ID: 32263744
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyaluronic acid and Arg-Gly-Asp peptide modified Graphene oxide with dual receptor-targeting function for cancer therapy.
    Guo Y; Xu H; Li Y; Wu F; Li Y; Bao Y; Yan X; Huang Z; Xu P
    J Biomater Appl; 2017 Jul; 32(1):54-65. PubMed ID: 28554233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.